[
  {
    "ts": "2026-02-11T18:34:00+00:00",
    "headline": "BD Merges Biosciences & Diagnostics Business With Waters",
    "summary": "BDX completes its Biosciences & Diagnostic spin-off and Waters merger, securing $4B in proceeds as it pivots to a pure-play MedTech focus.",
    "url": "https://finance.yahoo.com/news/bd-merges-biosciences-diagnostics-business-183400275.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "d181276e-2099-383d-9162-27d71c9c2a9e",
      "content": {
        "id": "d181276e-2099-383d-9162-27d71c9c2a9e",
        "contentType": "STORY",
        "title": "BD Merges Biosciences & Diagnostics Business With Waters",
        "description": "",
        "summary": "BDX completes its Biosciences & Diagnostic spin-off and Waters merger, securing $4B in proceeds as it pivots to a pure-play MedTech focus.",
        "pubDate": "2026-02-11T18:34:00Z",
        "displayTime": "2026-02-11T18:34:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/e34d884fa2c79bf8b02903b1effd4c0b",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/5efl.hfUE9GqHAAzVZOyrQ--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e34d884fa2c79bf8b02903b1effd4c0b.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/kZSi1jC0ojY5JbN8IL4CqA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/e34d884fa2c79bf8b02903b1effd4c0b.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/bd-merges-biosciences-diagnostics-business-183400275.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/bd-merges-biosciences-diagnostics-business-183400275.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "WAT"
            },
            {
              "symbol": "CAH"
            },
            {
              "symbol": "BDX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-11T22:09:11+00:00",
    "headline": "Why The Narrative Around Cardinal Health (CAH) Is Shifting With Fresh Targets And Fair Value Assumptions",
    "summary": "The fair value estimate for Cardinal Health has shifted from about US$230.27 to roughly US$243.07 per share, reflecting updated assumptions that use a slightly higher discount rate and a lower revenue growth outlook. Even with that softer growth assumption, recent analyst commentary around guidance, specialty expansion, and core distribution resilience has supported a higher price target. Stay tuned to see how you can keep on top of these moving assumptions and the evolving narrative around...",
    "url": "https://finance.yahoo.com/news/why-narrative-around-cardinal-health-220911883.html",
    "source": "Simply Wall St.",
    "provider": "yfinance",
    "raw": {
      "id": "1abb76a4-5883-38a3-8dea-2975e55eff14",
      "content": {
        "id": "1abb76a4-5883-38a3-8dea-2975e55eff14",
        "contentType": "STORY",
        "title": "Why The Narrative Around Cardinal Health (CAH) Is Shifting With Fresh Targets And Fair Value Assumptions",
        "description": "",
        "summary": "The fair value estimate for Cardinal Health has shifted from about US$230.27 to roughly US$243.07 per share, reflecting updated assumptions that use a slightly higher discount rate and a lower revenue growth outlook. Even with that softer growth assumption, recent analyst commentary around guidance, specialty expansion, and core distribution resilience has supported a higher price target. Stay tuned to see how you can keep on top of these moving assumptions and the evolving narrative around...",
        "pubDate": "2026-02-11T22:09:11Z",
        "displayTime": "2026-02-11T22:09:11Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/simply_wall_st__316/7b81df3b98c066a64c5064f2efa65471",
          "originalWidth": 1194,
          "originalHeight": 432,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/a3quAWbEFXtRvpT9JpU8Gg--~B/aD00MzI7dz0xMTk0O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/simply_wall_st__316/7b81df3b98c066a64c5064f2efa65471.cf.webp",
              "width": 1194,
              "height": 432,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/u3PGWX8rnz44.9Tyxbc4xA--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/simply_wall_st__316/7b81df3b98c066a64c5064f2efa65471.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Simply Wall St.",
          "url": "https://simplywall.st/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/why-narrative-around-cardinal-health-220911883.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/why-narrative-around-cardinal-health-220911883.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CAH"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]